Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 171   

Articles published

GSK 1,575.50 -20.50 (-1.28%)
price chart
Why Is Neil Woodford So Confident About GlaxoSmithKline plc?
Neil Woodford has put 6% of his funds under management into GlaxoSmithKline (LSE: GSK), and when you look at the headline dividend yield it's easy to see why.
3 Of The Best Pharmaceutical Stocks That Money Can Buy: GlaxoSmithKline plc ...
When top and bottom line growth are proving elusive for any company, a period of rationalisation and restructuring often follows. That's the current situation at GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), where sales and profit growth have stalled in ...
3 Great Growth Stocks For Savvy Investors: GlaxoSmithKline plc, Legal ...
Considering that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been steadily battered by a stream of patent expirations across key products, at first glance the pharma play not be an obvious pick for those seeking reliable earnings growth.
Why I'd Buy Tesco PLC, Hold GlaxoSmithKline plc & Dump Diageo PLC
Three stocks with three different risk profiles: Tesco (LSE: TSCO), GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE).
Morningstar Gives "A+" Credit Rating to GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (NYSE:GSK) has been given an �A+� credit rating by Morningstar. The firm's �A+� rating suggests that the company is a low default risk.
GlaxoSmithKline plc (ADR) to Close Its Pittsburg Office As It Consolidates ...  Bidness ETC
GlaxoSmithKline plc Coverage Initiated at Societe Generale (GSK)  The Legacy
5 Growth Greats You Simply Can't Ignore: GlaxoSmithKline plc, British American ...
The enduring effect of patent losses across key drugs is expected to keep earnings on the back foot at GlaxoSmithKline (LSE: GSK) for a little while longer. Indeed, the business is expected to clock up its fourth consecutive annual bottom line decline ...
GlaxoSmithKline plc vs Shire PLC: Which Pharma Stock Is The Better Buy?
2015 is forecast to be a challenging year for both GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Shire (LSE: SHP) (NASDAQ: SHPG.
Could Dynamic Duo Diageo plc And GlaxoSmithKline plc Make You A Millionaire?
The �1m mark is a key goal for many investors and the most effective way to hit this target is slowly, without taking excessive risks.
GlaxoSmithKline plc's "Hold" Rating Reaffirmed at Deutsche Bank (GSK)
Deutsche Bank reiterated their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Friday morning.
GlaxoSmithKline plc's "Underperform" Rating Reaffirmed at ...  The Legacy
Weekly Analysts' Ratings Changes for GlaxoSmithKline plc (GSK)  Mideast Time
My Perfect 2015 ISA: National Grid plc, Lloyds Banking Group PLC ...
One of the two big pharmaceuticals must be in my portfolio too, and there's little to choose between GlaxoSmithKline (LSE: GSK) and AstraZeneca. But it's Glaxo that gets my nod, because I think it's a little out of the spotlight at the moment. Though ...